Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 8
2005 7
2006 3
2007 7
2008 5
2009 13
2010 9
2011 10
2012 27
2013 27
2014 19
2015 16
2016 21
2017 19
2018 12
2019 22
2020 24
2021 27
2022 23
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
Mepolizumab treatment in patients with severe eosinophilic asthma.
Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators. Ortega HG, et al. N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199059 Free article. Clinical Trial.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study.
Wechsler ME, Menzies-Gow A, Brightling CE, Kuna P, Korn S, Welte T, Griffiths JM, Sałapa K, Hellqvist Å, Almqvist G, Lal H, Kaur P, Skärby T, Colice G; SOURCE study group. Wechsler ME, et al. Lancet Respir Med. 2022 Jul;10(7):650-660. doi: 10.1016/S2213-2600(21)00537-3. Epub 2022 Mar 29. Lancet Respir Med. 2022. PMID: 35364018 Clinical Trial.
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.
Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M; ZONDA Trial Investigators. Nair P, et al. N Engl J Med. 2017 Jun 22;376(25):2448-2458. doi: 10.1056/NEJMoa1703501. Epub 2017 May 22. N Engl J Med. 2017. PMID: 28530840 Free article. Clinical Trial.
KAAACI Guidelines for Allergen Immunotherapy.
Lee HY, Lee SM, Kang SY, Kim K, Kim JH, Ryu G, Min JY, Park KH, Park SY, Sung M, Lee Y, Yang EA, Jee HM, Ha EK, Shin YS, Chung EH, Choi SH, Koh YI, Kim ST, Nahm DH, Park JW, Shim JY, An YM, Han DH, Han MY, Lee YW, Choi JH; Korean Academy of Asthma Allergy and Clinical Immunology (KAAACI) Allergen Immunotherapy and Allergen Working Group. Lee HY, et al. Among authors: park jw. Allergy Asthma Immunol Res. 2023 Nov;15(6):725-756. doi: 10.4168/aair.2023.15.6.725. Allergy Asthma Immunol Res. 2023. PMID: 37957792 Free PMC article. Review.
Asthma Phenotype with Metabolic Dysfunction.
Park JW. Park JW. Yonsei Med J. 2022 Jan;63(1):1-7. doi: 10.3349/ymj.2022.63.1.1. Yonsei Med J. 2022. PMID: 34913278 Free PMC article. Review.
Revised Pollen Calendar in Korea.
Park JW. Park JW. Allergy Asthma Immunol Res. 2020 Mar;12(2):171-172. doi: 10.4168/aair.2020.12.2.171. Allergy Asthma Immunol Res. 2020. PMID: 32009317 Free PMC article. No abstract available.
Ultrasonography of the ankle joint.
Park JW, Lee SJ, Choo HJ, Kim SK, Gwak HC, Lee SM. Park JW, et al. Ultrasonography. 2017 Oct;36(4):321-335. doi: 10.14366/usg.17008. Epub 2017 Apr 5. Ultrasonography. 2017. PMID: 28535605 Free PMC article. Review.
Genetic Architectures and Cell-of-Origin in Glioblastoma.
Kim HJ, Park JW, Lee JH. Kim HJ, et al. Among authors: park jw. Front Oncol. 2021 Jan 21;10:615400. doi: 10.3389/fonc.2020.615400. eCollection 2020. Front Oncol. 2021. PMID: 33552990 Free PMC article. Review.
275 results